Summary. An experiment was conducted to (i) determine whether administration of recombinant bovine interferon-\g=a\I 1 (rBoIFN-\g=a\) attenuates oxytocin-induced release of prostaglandin F-2\g=a\and (ii) peak PGF-2\g=a\ response to oxytocin (peak value after injection minus mean concentration before injection) was 257\m=.\8 \ m=+-\ 60\m=.\3 pg/ml for control cows, 100\m=.\7\ m=+-\40\m=.\8 pg/ml for rBoIFN-IU and 124\m=.\9\ m=+-\ 40\m=.\4 pg/ml for rBoIFN-IM. It is concluded that rBoIFN-\g=a\can reduce oxytocin-induced PGFM release and may therefore extend the lifespan of the corpus luteum by interfering with events leading to luteolytic release of PGF from the uterus. Administration of rBoIFN-\g=a\ can cause acute changes in body temperature and circulating concentrations of progesterone that become less severe after repeated exposure to rBoIFN-\g=a\.
Introduction
Bovine trophoblast protein-1 (bTP-1) and ovine TP-1 (oTP-1) are proteins secreted in large quantity by Day 15-22 bovine conceptuses (Helmer et ai, 1987 (Helmer et ai, , 1989a Plante et ai, 1990 ) and by Day 13-21 ovine conceptuses (Godkin et ai, 1982) , respectively. These proteins are antiluteolytic and probably act by depressing endometrial prostaglandin F-2a secretion (Godkin et ai, 1984; Helmer et ai, 1989a, b) . They are members of the alpha-interferon family (Imakawa et ai, 1987 (Imakawa et ai, , 1989 Stewart et ai, 1987 Stewart et ai, , 1989 Charpigny et ai, 1988) and possess antiviral and immunosuppressive activity characteristic of other interferon (IFN) molecules (Pontzer et ai, 1988; Newton et ai, 1989; Plante et ai, 1990) .
It is likely that non-embryonic IFN-as can simulate the antiluteolytic effect of bTP-1 and oTP-1 when given to cyclic animals. Administration of recombinant bovine interferon-a, 1 (rBoIFN-a) in utero or intramuscularly on Days 14-21 to cycling cows prolonged interoestrous interval and cor¬ pus luteum (CL) lifespan (Plante et ai, 1988 (Plante et ai, , 1989 Newton et ai, 1990) . In sheep, continuous intrauterine infusion of rBoIFN-a from Day 9 to Day 19 extended luteal lifespan and reduced circulating concentrations of PGF-2a metabolite (Stewart et ai, 1989) . Also, human interferon-a inhibited secretion of PGF-2a by ovine endometrial cells (Salamonsen et ai, 1988 (Salamonsen et ai, , 1989 and nonembryonic interferons suppressed prostaglandin synthesis in other tissues (Dore-Duffy et ai, 1983; Boraschi et ai, 1985; Browning & Ribolini, 1987) .
Other reports indicate that interferons reduce circulating concentrations of steroid hormones.
In women, administration of interferon-a reduced oestradiol and progesterone concentrations in blood (Kaupilla et ai, 1982) ; in men, testosterone concentrations in serum were diminished after injection of interferon-a (Orava et ai, 1986) . Pretreatment with interferon-reduced human chorionic gonadotrophin (hCG)-stimulated testosterone secretion from cultured porcine Leydig cells (Orava, 1989) . Intramuscular injection of rBoIFN-a can also cause an acute decline in circu¬ lating concentrations of progesterone in heifers, as well as inducing hyperthermia (Newton et ai, 1990) . This hyperthermia could have additional consequences on endocrine and reproductive function (Biggers et ai, 1987; Putney et ai, 1988) . In the present study, it was evaluated whether intramuscular and intrauterine administration of rBoIFN-a extends luteal lifespan by reducing uterine release of PGF-2a. This was examined by testing the hypothesis that administration of rBoIFN-a reduces release of PGF-2a from the uterus in response to oxytocin. Secretion of PGF-2a from endometrium was monitored by measuring peripheral concentrations of 13,14-dihydro,15-keto-PGF-2a (PGFM), a stable metabolite of PGF2a that is a reliable indicator of PGF-2a release from uterine tissues (Kindahl et ai, 1976) . McCracken et ai (1981, 1984) hypothesized, using the sheep as an experimental model, that ovar¬ ian oestradiol acts to trigger luteolysis by increasing synthesis of endometrial oxytocin receptors. Subsequently, oxytocin, presumably secreted by the corpus luteum (CL) in cattle (Wathes et ai, 1983) , binds to these receptors to stimulate PGF-2a release. During early pregnancy in cattle, endometrial release of PGF-2a is attenuated in response to oestrogen (Thatcher et ai, 1984) and oxytocin (Lafrance & Goff, 1985) . Similar PGF responses were observed following an oestradiol injection on Day 18 of the oestrous cycle in cows receiving intrauterine infusion of conceptus secretory proteins (Knickerbocker et ai, 1986 ). Effects of rBoIFN-a on circulating progesterone and oestradiol-17ß concentrations, follicular status at Day 17 after oestrus and body temperature were also ascertained to evaluate potential side-effects.
Preparation ofrBoIFN-a. Intrauterine solutions of rBoIFN-were prepared as a 10 mg/ml solution in a commer¬ cial carrier buffer (placebo) containing 5 mg bovine serum albumin (BSA)/ml. For controls, a solution of 15 mg BSA/ml dissolved in placebo was prepared. These two solutions were loaded into 0-5 ml artificial insemination straws. For each straw, 200 µ of the respective solution was aspirated into the middle of the straw. The bolus was bracketed between air bubbles that, in turn, were bracketed between 100 µ D-PBS containing 100 iu penicillin/ml and 100 µg streptomycin/ml. Intramuscular injection solutions were composed of 2-5 mg rBoIFN-a/ml or 2-5 mg BSA/ml dissolved in the placebo solution.
Administration ofrBolFN-a. (1986) . The intra-assay and interassay coefficients of variation (CV) for three assays were 8-7 and 3-8%, respectively. Plasma collected from Day 14 to oestrus was also analysed for oestradiol concentrations by a previously validated radio¬ immunoassay (Guilbault et ai, 1987) . The intra-assay and interassay CV was 7-9 and 16-8%, respectively. Plasma samples obtained on Day 17 (10:00 to 13:00 h) were analysed for PGFM by an assay described by Guilbault et ai (1984) . The intra-assay and interassay CV was 8-2 and 15-6%, respectively.
Ovarian ultrasound. Real-time linear scanning ultrasonic examination was performed at 08:00 h on Day 17. Before examination, faecal material was removed from the rectum. The transducer was then inserted rectally and moved laterally over the ovaries to examine ovarian sequential sections for follicular populations. Size (Fig. 2) were not statistically different between groups before or after oxytocin injections. Before oxytocin injection, the between-animal variance in time trends (i.e. variance due to cow time) was less for cows receiving rBoIFN-IU "Data analysed were hormone concentrations collected from 0 to 2 h after oxytocin administration. Data were trans¬ formed using square roots prior to analysis. bSS (sums of squares); 'MS (mean squares); "treatment effect tested using cow (treatment) as the error term.
(P < 010) and rBoIFN-IM (P < 005) than for controls. This was so because treatment with rBoIFN-lowered between-cow differences in variability in PGFM concentrations, perhaps because pulsatile release of PGF-2a from the uterus was reduced.
After oxytocin, there was an overall increase in PGFM concentrations (time effect, < 0-001). Inspection of individual profiles indicated that oxytocin increased PGFM concentrations for four of five control cows, two of five cows treated with rBoIFN-IU and two of five cows treated with rBoIFN-IM. The peak PGFM response to oxytocin for control cows (257-8 ± 61-3 pg/ml) was greater (P < 005) than for cows treated with rBoIFN-a (100-7 ± 40-8 pg/ml for rBoIFN-IU and 124-9 ± 40-4 pg/ml for rBoIFN-IM). Differences between rBoIFN-IU and rBoIFN-IM were not significant. Average PGFM response to oxytocin (84-8 + 28-8 for control cows, 141 ± 19-5 pg/ml for rBoIFN-IU and 34-3 ± 5-9pg/ml for rBoIFN-IM; control versus rBoIFN-, < 005; rBoIFN-IU versus rBoIFN-IM, non-significant) was similar.
Regression analysis of values from 0 to 120 min after injection indicated that response curves for rBoIFN-treated animals were different from those of controls (heterogeneity of regression, < 001 ; see Table 1 ). The between-animal variance in time trends over the entire sampling period (i.e. variance due to cow time) was less for cows receiving rBoIFN-than for controls ( < 005), because of treatment effects on response to oxytocin. In the controls, most animals responded and there was considerable between-cow variability in the pattern of response over time. The between-cow variability in time trends was small for cows treated with rBoIFN-because most cows had stable and low concentrations of PGFM over time.
Discussion
In agreement with previous results (Plante et ai, 1988 (Plante et ai, , 1989 Newton et ai, 1990) , intramuscular and intrauterine administration of rBoIFN-extended interoestrous interval and CL lifespan. Results suggest that luteal maintenance may have involved changes in uterine release of PGF-2a, as oxytocin-induced PGFM was reduced in most cases in IFN-treated cows. This is similar to the situation in early pregnancy when endometrial release of PGF-2a induced by oestra¬ diol (Thatcher et ai, 1984) and oxytocin (Lafrance & Goff, 1985; Putney et ai, 1989) (Knickerbocker et ai, 1986) . Furthermore, bTP-1 (Helmer et ai, 1989b ) and other interferons (Salamonsen et ai, 1988 (Salamonsen et ai, , 1989 Of interest in the current study was the finding that some of the cows treated with rBoIFN-a had high basal concentrations of PGFM and responded markedly to oxytocin. Cycle length was extended in these cows and it is not known why they failed to show clear suppression of PGFM concentrations. One possibility is that other actions of rBoIFN-may also promote extension of corpus luteum function. In the present study, possible effects of rBoIFN-on ovarian follicles were examined. The ovarian follicular population has been shown to play an important role in luteolysis as destruction of the follicular population around Days 9-15 of the oestrous cycle extends luteal lifespan (Hughes et ai, 1987) . As interferons can reduce circulating concentration of oestradiol-17ß in women (Kaupilla et ai, 1982) , it is possible that rBoIFN-delays luteolysis by suppressing follicles that initiate luteolysis. An intensive survey of follicular growth was not carried out, but there were no significant effects of rBoIFN-on follicular characteristics at Day 17 or on oestradiol-17ß concentrations from Day 14 to Day 17.
In the present study, rBoIFN-induced an acute pyrogenic effect, with peak hyperthermia at 6 h after administration. This effect was not seen after subsequent injections. As expected, the intramuscular injection of rBoIFN-was more pyrogenic than intrauterine infusion, probably because of dose differences (10 vs. 2 mg). A significant decline in serum concentrations of progester¬ one in cows treated with rBoIFN-IM coincided with the peak of hyperthermia at Day 14. Other depressions in progesterone concentrations caused by rBoIFN-IM were seen on Days 15-17, though of lower magnitude than on Day 14 and not temporally associated with hyperthermia. An acute effect of intramuscular injection of rBoIFN-on circulating progesterone concentrations has also been reported elsewhere (Newton et ai, 1990) . In the studies of Plante et al. (1989) , no inhibi¬ tory effects of rBoIFN-on serum concentrations of progesterone were observed. This is not surprising because progesterone concentrations were measured 12 h or more after administration of rBoIFN-, when they would have returned to values similar to those before injection (Newton et ai, 1990) .
From the present study and the literature (Kaupilla et ai, 1982; Orava et ai, 1986; Orava, 1989) , it is clear that interferons can depress circulating concentrations of certain steroids when administered intramuscularly. In particular, rBoIFN-has two distinct effects on progesterone concentrations in cows (Plante et ai, 1988 (Plante et ai, , 1989 Newton et ai, 1990; present results). First, rBoIFN-extends the lifespan of the corpus luteum, probably through its actions on endometrial prostaglandin release. Secondly, rBoIFN-causes a short-term (6-8 h) depression in circulating con¬ centrations of progesterone that probably occurs through mechanisms distinct from effects of rBoIFN-on luteal lifespan. This latter effect of rBoIFN-is reduced after repeated exposure to rBoIFN-a. Although the possible use of rBoIFN-a to increase fertility in cattle by acting in an antiluteoly¬ tic support role is plausible, the pyrogenic effects manifested by rBoIFN-, as well as the depression
